Keith Crandell
InvestorCo-founder & Managing Director at ARCH Venture Partners · Board director at Vizgen · Board director at Arbor Biotechnologies · Board director at Ultivue
Chicago, Illinois
Writes $50K – $150M checks · typically $25M
About
Keith Crandell follows a follow-the-science approach, prioritizing powerful scientific platforms and tools-focused investments, arguing that better, faster, cheaper measurements—echoing the semiconductor measurement revolution—enable biotech breakthroughs.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- k•••@archventure.comreveal100% confident
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Board director at Vizgen
Intro paths
In turn, Keith can intro founders to Vizgen's investors below.
Vizgen's investors · 4
Co-founders at Vizgen
Board director at Arbor Biotechnologies
Intro paths
In turn, Keith can intro founders to Arbor Biotechnologies's investors below.
Arbor Biotechnologies's investors · 5
Co-founders at Arbor Biotechnologies
Board director at Ultivue
Intro paths
In turn, Keith can intro founders to Ultivue's investors below.
Ultivue's investors · 2
Co-founders at Ultivue
Deals · 7
Arbor BiotechnologiesBoard seat
via ARCH Venture Partners · filed Nov 2021 · $215M raise
Cytrellis BiosystemsBoard seat
via ARCH Venture Partners · filed Jan 2021 · $50M raise
QuanterixBoard seat
via ARCH Venture Partners · filed Jul 2019 · $6.5M raise
Twist BioscienceBoard seat
via ARCH Venture Partners · filed Dec 2017 · $75M raise
Adesto TechnologiesBoard seat
via ARCH Venture Partners · filed Sep 2015 · $12.5M raise
908 DevicesBoard seat
via ARCH Venture Partners · filed May 2015
NanosysBoard seat
via ARCH Venture Partners · filed Mar 2015 · $10M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Per SEC Form D filings.
Colleagues at ARCH Venture Partners
Network1
Investors connected to Keith in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Keith Crandell?
- Keith Crandell follows a follow-the-science approach, prioritizing powerful scientific platforms and tools-focused investments, arguing that better, faster, cheaper measurements—echoing the semiconductor measurement revolution—enable biotech breakthroughs.
- Where does Keith Crandell work?
- Keith Crandell is Co-founder & Managing Director at ARCH Venture Partners and Board director at Vizgen and Board director at Arbor Biotechnologies and Board director at Ultivue.
- What does Keith Crandell invest in?
- Keith Crandell invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Keith Crandell write?
- Keith Crandell typically writes checks of $50K – $150M.
- What boards does Keith Crandell sit on?
- Keith Crandell holds tracked board seats at 908 Devices, Adesto Technologies, Arbor Biotechnologies, Cytrellis Biosystems, Nanosys, Quanterix, Twist Bioscience, Ultivue, Vizgen.